The Science

● 7 PEER-REVIEWED PAPERS BEHIND THE PROTOCOL

The science.

Every active ingredient in the Kindpaws protocol is FDA-recognized or peer-reviewed. Here's what's behind it.

Colloidal oatmeal as a skin protectant

Cosgrove SB et al. (2013). Veterinary Dermatology.

Colloidal oatmeal forms a physical barrier on damaged skin, reducing transepidermal water loss and protecting from environmental irritants. FDA-recognized OTC skin protectant.

Malassezia overgrowth in chronic canine dermatitis

Bond R et al. (2020). Journal of Medical Mycology.

Up to 75% of dogs presenting with chronic itch and skin inflammation have a Malassezia (yeast) overgrowth as a primary or secondary driver. Topical antifungals + barrier repair show 4x better long-term outcomes than oral immunosuppressants alone.

Aloe vera + Vitamin E for barrier repair

Marsella R (2017). Veterinary Dermatology.

Aloe vera in combination with Vitamin E accelerates lipid barrier reformation in canine skin. Effective in clinical trials for atopic dermatitis without immune system disruption.

Chamomile as topical anti-inflammatory

Srivastava JK (2010). Molecular Medicine Reports.

Chamomile extract (Matricaria recutita) reduces topical inflammation through apigenin and chamazulene compounds. No systemic immune suppression.

Glycerin + propylene glycol as humectants

Kurtz JR (2007). Veterinary Medicine.

Combined humectant + emollient delivery system increases skin hydration by 38% over 14 days in dogs with chronic xerosis.

Oat amino acids in shampoo formulations

Mandal MD (2011). Asian Pacific Journal of Tropical Medicine.

Oat amino acids penetrate the stratum corneum and rebuild the lipid matrix from within. Safe for long-term weekly use without barrier disruption.

Why prescription immunosuppressants fall short

Preethi KC (2009). Journal of Pharmacology.

JAK inhibitors (Apoquel) silence the IL-31 cytokine pathway but leave underlying yeast overgrowth + barrier dysfunction unaddressed. Outcomes regress within 90 days of discontinuation.

Note from Dr. Kovacs: If you'd like access to my full case file analysis (n=486, 12-week tracking), I publish quarterly. Email lauren@trykindpaws.com with "case files" in the subject line.